Physician profile
Jerry E Berland
NPI 1043217458
$1,712.58
in general payments reported to CMS, 2019-2025
13 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.74 · 2020: $190 · 2021: $394 · 2022: $467 · 2023: $177 · 2024: $297 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $500.00 | 2021-2022 | |
| Abbvie INC. | $238.98 | 2024-2025 | |
| Amgen INC. | $202.81 | 2024-2025 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $172.56 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $144.03 | 2021 | |
| Biotissue Holdings INC. | $143.64 | 2023 | |
| Eyepoint US, INC. | $127.79 | 2022 | |
| Alcon Vision LLC | $89.29 | 2022 | |
| Horizon Therapeutics Plc | $33.71 | 2023 | Tepezza |
| Bausch & Lomb Americas INC. | $24.84 | 2025 | Vyzulta |
| Spark Therapeutics, INC. | $17.74 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.53 | 2020 | |
| Travere Therapeutics, INC. | $1.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Berland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.